Aspire Biopharma Holdings Inc. has announced a Special Meeting of Stockholders scheduled for November 4, 2025, in Provo, UT. During this meeting, stockholders will vote on granting discretionary authority to the company's board of directors to amend the company's certificate of incorporation. This amendment involves effecting a reverse stock split of all outstanding shares of common stock by a ratio in the range of one-for-five.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-026871), on September 08, 2025, and is solely responsible for the information contained therein.